PL333169A1 - Sequences of nucleic and amino acids associated with helicobacter pylori, and vaccines - Google Patents

Sequences of nucleic and amino acids associated with helicobacter pylori, and vaccines

Info

Publication number
PL333169A1
PL333169A1 PL97333169A PL33316997A PL333169A1 PL 333169 A1 PL333169 A1 PL 333169A1 PL 97333169 A PL97333169 A PL 97333169A PL 33316997 A PL33316997 A PL 33316997A PL 333169 A1 PL333169 A1 PL 333169A1
Authority
PL
Poland
Prior art keywords
vaccines
nucleic
sequences
amino acids
helicobacter pylori
Prior art date
Application number
PL97333169A
Other languages
English (en)
Inventor
Douglas Smith
Richard A Alm
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of PL333169A1 publication Critical patent/PL333169A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Analytical Chemistry (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL97333169A 1996-10-28 1997-10-28 Sequences of nucleic and amino acids associated with helicobacter pylori, and vaccines PL333169A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US73915096A 1996-10-28 1996-10-28
US75973996A 1996-12-06 1996-12-06
US89192897A 1997-07-14 1997-07-14

Publications (1)

Publication Number Publication Date
PL333169A1 true PL333169A1 (en) 1999-11-22

Family

ID=27419246

Family Applications (1)

Application Number Title Priority Date Filing Date
PL97333169A PL333169A1 (en) 1996-10-28 1997-10-28 Sequences of nucleic and amino acids associated with helicobacter pylori, and vaccines

Country Status (19)

Country Link
EP (1) EP0973394A4 (no)
JP (1) JP2001504329A (no)
KR (1) KR20000052831A (no)
CN (1) CN1235513A (no)
AR (1) AR009600A1 (no)
AU (1) AU734052B2 (no)
BR (1) BR9712587A (no)
CA (1) CA2265523A1 (no)
EE (1) EE9900176A (no)
ID (1) ID22065A (no)
IL (1) IL129397A0 (no)
IS (1) IS5005A (no)
NO (1) NO991995L (no)
NZ (1) NZ334568A (no)
PL (1) PL333169A1 (no)
SA (1) SA98180918A (no)
SK (1) SK34699A3 (no)
TR (1) TR199900940T2 (no)
WO (1) WO1998018323A1 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0716613B1 (en) * 1993-07-27 2003-07-09 Csl Limited Treatment of helicobacter associated gastroduodenal disease
US6406703B1 (en) 1993-07-27 2002-06-18 Csl Limited Treatment of H. pylori associated gastroduodenal disease
DE19730425A1 (de) 1997-07-16 1999-01-21 Henkel Teroson Gmbh Heißhärtende wäschefeste Rohbau-Versiegelung
AU4793499A (en) * 1998-07-27 2000-02-21 Aventis Pasteur Limited (chlamydia) antigens and corresponding dna fragments and uses thereof
SE9901548D0 (sv) * 1999-04-29 1999-04-29 Astra Ab Helicobacter pylori antigens
GB9914945D0 (en) * 1999-06-25 1999-08-25 Smithkline Beecham Biolog Novel compounds
AUPQ347199A0 (en) * 1999-10-15 1999-11-11 Csl Limited Novel polypeptide fragments
EP2302048B1 (en) 2000-03-08 2014-07-09 Novozymes A/S Variants with altered properties
GB0010371D0 (en) * 2000-04-29 2000-06-14 Astrazeneca Ab Helicobacter pylori antigens
GB0010370D0 (en) * 2000-04-29 2000-06-14 Astrazeneca Ab Helicobacter pylori antigens
EP2695938B1 (en) * 2011-03-17 2016-11-30 National UniversityCorporation Mie University Antibody production method
AU2016374289B2 (en) * 2015-12-14 2023-08-03 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Helicobacter pylori vaccines
CN115724922B (zh) * 2022-07-19 2023-08-22 四川大学华西医院 一种幽门螺杆菌疫苗重组蛋白抗原TonB及其制备方法与应用
CN115581201A (zh) * 2022-08-26 2023-01-10 云南省农业科学院花卉研究所 以茎段为外植体诱导的二倍体月季f1-61的植株再生方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9300139L (sv) * 1993-01-19 1994-07-20 Medicarb Ab Framställning av ett nytt läkemedel

Also Published As

Publication number Publication date
NZ334568A (en) 2000-04-28
AU5093398A (en) 1998-05-22
NO991995D0 (no) 1999-04-27
AU734052B2 (en) 2001-05-31
NO991995L (no) 1999-06-28
EE9900176A (et) 1999-12-15
CN1235513A (zh) 1999-11-17
AR009600A1 (es) 2000-04-26
SA98180918A (ar) 2005-12-03
EP0973394A4 (en) 2005-03-30
SK34699A3 (en) 2000-04-10
CA2265523A1 (en) 1998-05-07
WO1998018323A1 (en) 1998-05-07
ID22065A (id) 1999-08-26
IS5005A (is) 1999-03-18
EP0973394A1 (en) 2000-01-26
KR20000052831A (ko) 2000-08-25
BR9712587A (pt) 1999-10-26
JP2001504329A (ja) 2001-04-03
IL129397A0 (en) 2000-02-17
TR199900940T2 (xx) 1999-09-21

Similar Documents

Publication Publication Date Title
EP0821737A4 (en) NUCLEOTIDE SEQUENCE OF THE GENOME HAEMOPHILUS INFLUENZAE RD, THE FRAGMENTS THEREOF, AND ITS APPLICATIONS
PL333943A1 (en) Sequences of nucleic and amino acids associated with heliobacter pylori and vaccines containing such sequences
IL125808A0 (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
IL129397A0 (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
EP1409683A4 (en) HELICOBACTER PROTEINS, NUCLEIC ACIDS AND THEIR USE
IL132976A0 (en) Rupestris stem pitting associated virus nucleic acids proteins and their use
ZA979672B (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine composition thereof
ZA972715B (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof.
ZA9710971B (en) Nucleic acid and amino acid sequences relating to Helicobacter pylori and vaccine compositions thereof.
PL337503A1 (en) Vaccines containing f1ge polypeptide from helicobacter pylori
AU7212098A (en) (helicobacter) aliphatic amidase amie polypeptides, and dna sequences encoding those polypeptides
IL122626A0 (en) Nucleic acids encoding hev structural proteins hev structural proteins encoded thereby and uses thereof
HK1024176A (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
HK1017385A (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
HK1024597A (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
HUP9903843A3 (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
HUP0000521A3 (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
GB9828022D0 (en) Enzyme and DNA sequence encoding same
EE9700373A (et) Helicobacter pyloriga seotud nukleiinhapete ja aminohapete järjestused diagnoosimiseks ja raviks
IL116541A0 (en) Helicobacter proteins and vaccines
GB2330142B (en) Nucleotide sequences and protein sciences
GB9721357D0 (en) Nucleotide sequences and protein sequences
GB9721358D0 (en) Nucleotide sequences and protein sequences
IL120283A0 (en) Nucleic acid sequences and proteins
GB9502480D0 (en) DNA and protein sequences